Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.
Saved in:
| Title: | Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials. |
|---|---|
| Authors: | Bouxsein ML (AUTHOR), Chen P (AUTHOR), Glass EV (AUTHOR), Kallmes DF (AUTHOR), Delmas PD (AUTHOR), Mitlak BH (AUTHOR), Bouxsein, Mary L1 (AUTHOR), Chen, Peiqi (AUTHOR), Glass, Emmett V (AUTHOR), Kallmes, David F (AUTHOR), Delmas, Pierre D (AUTHOR), Mitlak, Bruce H (AUTHOR) |
| Source: | Journal of Bone & Joint Surgery, American Volume. Jun2009, Vol. 91 Issue 6, p1329-1338. |
| Database: | SPORTDiscus with Full Text |
Be the first to leave a comment!
